Conditions

In patients with type 2 diabetes, LX4211 produced greater dose-ranging effects on HbA1c than on glucosuria…. 

Vagal nerve blockade might not be an effective therapy for obesity treatment…. 

The meta-analysis also showed risks for certain cancers increased 22% with a prediabetes diagnosis…. 

A long-term UK study revealed that in order to prevent poorer health outcomes, changes need to be made to the current way of diagnosing patients with type 2 diabetes…. 

The FDA first rejected the drug combination in February 2011, asking the company to conduct a cardiovascular-outcomes trial because of concerns about the CV safety profile of bupropion/naltrexone when used long-term in a population of overweight and obese subjects…. 

Metformin seems to have positive effects on body composition, insulin sensitivity, and glucose homeostasis in patients recently diagnosed with type 2 diabetes…. 

Slow caffeine metabolizers who drink more than three cups a day have the highest risk…. 

About one in every 1,000 individuals carries a variant in PPARG, which is treatable with tailored pharmacotherapy…. 

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP   Lifestyle modification The starting points and mainstays of treatment for type 2 diabetes are diet and other modifications of lifestyle, such as increasing exercise and stopping smoking (Figure 11.1). The major aims are to reduce the weight of obese patients and …

Children who reported eating a high fiber, cereal breakfast also had lower insulin resistance….